{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Shao D"],"funding":["Leading Health Talents in Zhejiang Province","Natural Science Foundation of Zhejiang Province","Science and Technology Development Program of Hangzhou","Hangzhou Joint Fund of the Zhejiang Provincial Natural Science Foundation of China","National Natural Science Foundation of China","National Key Research and Development Program of China"],"pagination":["38760"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12589550"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["15(1)"],"pubmed_abstract":["Circular single-stranded DNA (cssDNA), an emerging nucleic acid vector, exhibits significant clinical potential for treating genetic disorders, enabling gene editing, and advancing oncotherapy. Its unique attributes, including high stability, structural simplicity, conformational flexibility, and low molecular mass, establish it as a promising gene therapy tool. Our study reveals that cssDNA demonstrates superior expression efficiency over conventional plasmids across diverse tumor cell lines. Notably, cssDNA expression is enhanced under certain tumor microenvironment (TME) conditions (glucose deficiency, glutamine deficiency and hypoxia) compared to normal condition. Mechanistically, these TME conditions induce significant cell cycle perturbations, particularly pronounced G1 arrest. Intri"],"journal":["Scientific reports"],"pubmed_title":["The tumor microenvironment enhances the expression of cssDNA by modulating cell cycle signaling pathways via SKP2."],"pmcid":["PMC12589550"],"funding_grant_id":["LHZY24H300002","22161132008","YXD23B0301","WS2022LJ01","202204B04","2021YFF1200200"],"pubmed_authors":["Zou K","Chen Y","Wang J","Shao D","Song J","Zhang P"],"additional_accession":[]},"is_claimable":false,"name":"The tumor microenvironment enhances the expression of cssDNA by modulating cell cycle signaling pathways via SKP2.","description":"Circular single-stranded DNA (cssDNA), an emerging nucleic acid vector, exhibits significant clinical potential for treating genetic disorders, enabling gene editing, and advancing oncotherapy. Its unique attributes, including high stability, structural simplicity, conformational flexibility, and low molecular mass, establish it as a promising gene therapy tool. Our study reveals that cssDNA demonstrates superior expression efficiency over conventional plasmids across diverse tumor cell lines. Notably, cssDNA expression is enhanced under certain tumor microenvironment (TME) conditions (glucose deficiency, glutamine deficiency and hypoxia) compared to normal condition. Mechanistically, these TME conditions induce significant cell cycle perturbations, particularly pronounced G1 arrest. Intri","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Nov","modification":"2026-06-05T14:55:57.754Z","creation":"2026-05-18T03:13:06.606Z"},"accession":"S-EPMC12589550","cross_references":{"pubmed":["41193507"],"doi":["10.1038/s41598-025-22477-2"]}}